ATE458052T1 - Verfahren zu chemokinrezeptor 88c - Google Patents

Verfahren zu chemokinrezeptor 88c

Info

Publication number
ATE458052T1
ATE458052T1 AT07013395T AT07013395T ATE458052T1 AT E458052 T1 ATE458052 T1 AT E458052T1 AT 07013395 T AT07013395 T AT 07013395T AT 07013395 T AT07013395 T AT 07013395T AT E458052 T1 ATE458052 T1 AT E458052T1
Authority
AT
Austria
Prior art keywords
chemokine receptors
modulators
ligands
polynucleotides
chemokine receptor
Prior art date
Application number
AT07013395T
Other languages
English (en)
Inventor
Patrick W Gray
Vicki L Schweickart
Carol J Raport
Original Assignee
Euroscreen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24302427&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE458052(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Euroscreen Sa filed Critical Euroscreen Sa
Application granted granted Critical
Publication of ATE458052T1 publication Critical patent/ATE458052T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07013395T 1995-12-20 1996-12-20 Verfahren zu chemokinrezeptor 88c ATE458052T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/575,967 US6265184B1 (en) 1995-12-20 1995-12-20 Polynucleotides encoding chemokine receptor 88C
US08/661,393 US6268477B1 (en) 1995-12-20 1996-06-07 Chemokine receptor 88-C

Publications (1)

Publication Number Publication Date
ATE458052T1 true ATE458052T1 (de) 2010-03-15

Family

ID=24302427

Family Applications (2)

Application Number Title Priority Date Filing Date
AT96945669T ATE309349T1 (de) 1995-12-20 1996-12-20 Chemokinrezeptor 88c sowie dessen antikörper
AT07013395T ATE458052T1 (de) 1995-12-20 1996-12-20 Verfahren zu chemokinrezeptor 88c

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT96945669T ATE309349T1 (de) 1995-12-20 1996-12-20 Chemokinrezeptor 88c sowie dessen antikörper

Country Status (17)

Country Link
US (7) US6265184B1 (de)
EP (3) EP1642975A3 (de)
JP (4) JP3288384B2 (de)
CN (2) CN1222617C (de)
AT (2) ATE309349T1 (de)
AU (1) AU730463B2 (de)
BR (1) BR9607300A (de)
CA (1) CA2213331C (de)
CZ (1) CZ261097A3 (de)
DE (2) DE69635406T3 (de)
DK (2) DK1870465T3 (de)
ES (2) ES2341371T3 (de)
HU (1) HUP9801127A3 (de)
NO (2) NO973800L (de)
PL (2) PL192071B1 (de)
SK (1) SK112897A3 (de)
WO (1) WO1997022698A2 (de)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537764B1 (en) 1995-01-19 2003-03-25 Children's Medical Center Corporation Method of identifying inhibitors of C—C chemokine receptor 3
US6806061B1 (en) 1995-01-19 2004-10-19 Children's Medical Center Corporation G protein-coupled receptor gene and methods of use therefor
US6743594B1 (en) 1995-06-06 2004-06-01 Human Genome Sciences, Inc. Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
US20040151719A1 (en) * 1995-06-06 2004-08-05 Human Genome Sciences, Inc. Human G-protein chemokine receptor (CCR5) HDGNR10
US6025154A (en) * 1995-06-06 2000-02-15 Human Genome Sciences, Inc. Polynucleotides encoding human G-protein chemokine receptor HDGNR10
DE69637890D1 (de) * 1995-06-07 2009-05-14 Progenics Pharm Inc Monoklonaler antikörper für die inhibierung von hiv-1-hüllgykoprotein-vermittelte membranfusion
US7018627B1 (en) 1995-06-07 2006-03-28 Icos Corporation Macrophage derived chemokine (MDC), MDC analogs, MDC inhibitor substances, and uses thereof
US6265184B1 (en) 1995-12-20 2001-07-24 Icos Corporation Polynucleotides encoding chemokine receptor 88C
US7118859B2 (en) * 1996-01-17 2006-10-10 Progenics Pharmaceuticals, Inc. Methods for inhibiting HIV-1 infection
AU1834197A (en) * 1996-01-30 1997-08-22 National Institutes Of Health, The Cells expressing both human cd4 and cxcr4
DE69739366D1 (de) * 1996-03-01 2009-05-28 Euroscreen Sa Aktive und inactive CC-Chemokinrezeptoren und Nukleinsäuremoleküle, die für diesen Rezeptor kodieren
US7858298B1 (en) * 1996-04-01 2010-12-28 Progenics Pharmaceuticals Inc. Methods of inhibiting human immunodeficiency virus type 1 (HIV-1) infection through the administration of CCR5 chemokine receptor antagonists
US6344545B1 (en) * 1996-06-14 2002-02-05 Progenics Pharmaceuticals, Inc. Method for preventing HIV-1 infection of CD4+ cells
EP0915969A4 (de) 1996-04-02 2002-04-17 Progenics Pharm Inc Unterdrückung der infektion von cd4+ zellen durch hiv
WO1997041154A1 (en) * 1996-04-26 1997-11-06 Merck & Co., Inc. Eosinophil eotaxin receptor
US6271347B1 (en) * 1996-04-26 2001-08-07 Merck & Co., Inc. Eosinophil eotaxin receptor
AU2813297A (en) * 1996-04-26 1997-11-19 Incyte Pharmaceuticals, Inc. Mammalian mixed lymphocyte receptors, chemokine receptors {mmlr-ccr}
US5939320A (en) * 1996-05-20 1999-08-17 New York University G-coupled receptors associated with macrophage-trophic HIV, and diagnostic and therapeutic uses thereof
US6258527B1 (en) 1996-05-20 2001-07-10 The Aaron Diamond Aids Research Center Methods of identifying g-coupled receptors associated with macrophage-trophic HIV, and diagnostic and therapeutic uses thereof
AU3375697A (en) 1996-05-28 1998-01-05 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Cc chemokine receptor 5, antibodies thereto, transgenic animals
US20040086528A1 (en) * 1996-06-14 2004-05-06 Progenics Pharmaceuticals, Inc. Uses of a chemokine receptor for inhibiting HIV-1 infection
US6057102A (en) * 1996-08-08 2000-05-02 The Aaron Diamond Aids Research Center HIV coreceptor mutants
US6388055B1 (en) * 1996-10-03 2002-05-14 Smithkline Beecham Corporation Mouse CC-CKR5 receptor polypeptide
US6528625B1 (en) 1996-10-28 2003-03-04 Millennium Pharmaceuticals, Inc. Anti-CCR5 antibodies and kits comprising same
US6153431A (en) * 1997-05-30 2000-11-28 Fond Mondiale Rech & Prev Sida Human immunodeficiency virus co-receptor variants associated with resistance to virus infection
US6465237B1 (en) * 1997-07-01 2002-10-15 Millennium Pharmaceuticals, Inc. Cloning and characterization of a human adenylyl cyclase
US7067117B1 (en) 1997-09-11 2006-06-27 Cambridge University Technical Services, Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6989435B2 (en) 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6204024B1 (en) * 1997-09-12 2001-03-20 Akzo Nobel N.V. CCR5 RNA transcription based amplification assay
US6287805B1 (en) 1998-03-20 2001-09-11 Millennium Pharmaceuticals, Inc. Nucleic acid molecules of the protein-coupled heptahelical receptor superfamily and uses therefor
CA2235420A1 (en) 1998-06-17 1999-12-17 Paolo Renzi Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
US20080015348A1 (en) * 1998-12-16 2008-01-17 Progenics Pharmaceuticals, Inc. Nucleic acids encoding polypeptides of anti-CCR5 antibodies
US20040228869A1 (en) * 1998-12-16 2004-11-18 Progenics Pharmaceuticals, Inc. Synergistic inhibition of HIV-1 fusion and attachment, compositions and antibodies thereto
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
JP4712975B2 (ja) 1999-01-12 2011-06-29 ケンブリッジ エンタープライズ リミティド 炎症反応を阻害又は増強するための組成物及び方法
AU2001243145A1 (en) * 2000-02-09 2001-08-20 Human Genome Sciences, Inc. Human g-protein chemokine receptor (ccr5) hdgnr10
WO2002014532A2 (en) 2000-08-15 2002-02-21 Millennium Pharmaceuticals, Inc. Method for identifying modulators of 'mec'-induced functions of ccr3 and/or ccr10
US7138119B2 (en) * 2000-09-15 2006-11-21 Progenics Pharmaceuticals, Inc. Compositions and methods for inhibition of HIV-1 infection
US7175988B2 (en) * 2001-02-09 2007-02-13 Human Genome Sciences, Inc. Human G-protein Chemokine Receptor (CCR5) HDGNR10
US7060273B2 (en) * 2001-04-06 2006-06-13 Progenics Pharmaceuticals, Inc. Methods for inhibiting HIV-1 infection
US20030104496A1 (en) * 2001-11-30 2003-06-05 Cytokinetics, Inc. Novel motor protein of P. falciparum and methods for its use
US7393934B2 (en) * 2001-12-21 2008-07-01 Human Genome Sciences, Inc. Human G-protein chemokine receptor (CCR5) HDGNR10
US20050069549A1 (en) 2002-01-14 2005-03-31 William Herman Targeted ligands
ES2351678T3 (es) * 2002-01-18 2011-02-09 Zymogenetics, Inc. Ligando de citocina para el tratamiento de asma e hiper-sensibilidad de las vías respiratorias .
US7122185B2 (en) * 2002-02-22 2006-10-17 Progenics Pharmaceuticals, Inc. Anti-CCR5 antibody
WO2003072014A2 (en) 2002-02-25 2003-09-04 Mpex Bioscience, Inc. Minicell compositions and methods
US7094848B2 (en) * 2003-05-13 2006-08-22 Exxonmobil Chemical Patents Inc. Olefin polymerization catalyst system
WO2005105841A2 (en) * 2004-03-12 2005-11-10 Human Genome Sciences, Inc. Human g-protein chemokine receptor (ccr5) hdgnr10
WO2005106492A2 (en) * 2004-04-30 2005-11-10 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 3 (ccr3)
BRPI0517387A8 (pt) 2004-10-29 2017-07-11 Topigen Pharmaceuticals Inc Oligonucleotídeos anti-senso para o tratamento de alergia e proliferação de células neoplásicas
US20070026441A1 (en) * 2005-07-22 2007-02-01 Olson William C Methods for reducing viral load in HIV-1-infected patients
WO2007084568A2 (en) 2006-01-17 2007-07-26 Health Research, Inc. Heteroduplex tracking assay
US20080283557A1 (en) * 2007-05-17 2008-11-20 Julianne Desautels Spout for food stuff container
US8200440B2 (en) 2007-05-18 2012-06-12 Affymetrix, Inc. System, method, and computer software product for genotype determination using probe array data
US20090074766A1 (en) * 2007-09-14 2009-03-19 Ketas Thomas J Methods of inhibiting HIV-2 infection
ES2625406T3 (es) 2010-03-25 2017-07-19 Oregon Health & Science University Glicoproteínas de CMV y vectores recombinantes
SI2691530T1 (en) 2011-06-10 2018-08-31 Oregon Health & Science University CMV glycoproteins and recombinant vectors
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
EP2679596B1 (de) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 Env-proteinvariante
DE102013200909A1 (de) * 2013-01-22 2014-07-24 Robert Bosch Gmbh Brennstoffeinspritzanlage mit einer Brennstoff führenden Komponente, einem Brennstoffeinspritzventil und einem Verbindungselement
EP2848937A1 (de) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
CN106405067B (zh) * 2016-08-31 2018-03-30 徐州医科大学 一种基于全细胞的药物靶点停留时间的检测方法
JP6378735B2 (ja) * 2016-11-09 2018-08-22 本田技研工業株式会社 スイッチユニット

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886742A (en) 1987-06-15 1989-12-12 Coulter Corporation Enzyme immunoassay for detecting HIV antigens in human sera
US4888920A (en) 1988-08-24 1989-12-26 Marulic Walter J Gutter anti-clogging device
US5215915A (en) 1991-04-16 1993-06-01 Duke University Cloned gene encoding rat d1b dopamine receptor
US6806061B1 (en) 1995-01-19 2004-10-19 Children's Medical Center Corporation G protein-coupled receptor gene and methods of use therefor
EP1148127A3 (de) 1995-06-06 2003-12-03 Human Genome Sciences, Inc. Menschlicher G-Protein ChemokinRezeptor HDGNR10 (CCR5 Rezeptor). Seine verwendungen
WO1996039437A1 (en) 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Human g-protein chemokine receptor hdgnr10
US6025154A (en) 1995-06-06 2000-02-15 Human Genome Sciences, Inc. Polynucleotides encoding human G-protein chemokine receptor HDGNR10
US6512103B1 (en) 1995-12-08 2003-01-28 Schering Corporation Mammalian chemokine reagents
US6265184B1 (en) 1995-12-20 2001-07-24 Icos Corporation Polynucleotides encoding chemokine receptor 88C
WO1997026009A1 (en) 1996-01-17 1997-07-24 Progenics Pharmaceuticals, Inc. Compounds capable of inhibiting hiv-1 infection
DE69739366D1 (de) 1996-03-01 2009-05-28 Euroscreen Sa Aktive und inactive CC-Chemokinrezeptoren und Nukleinsäuremoleküle, die für diesen Rezeptor kodieren
US5939320A (en) 1996-05-20 1999-08-17 New York University G-coupled receptors associated with macrophage-trophic HIV, and diagnostic and therapeutic uses thereof
AU3375697A (en) 1996-05-28 1998-01-05 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Cc chemokine receptor 5, antibodies thereto, transgenic animals
CA2257991A1 (en) 1996-06-14 1997-12-18 Progenics Pharmaceuticals, Inc. Uses of a chemokine receptor for inhibiting hiv-1 infection
US5994515A (en) * 1996-06-25 1999-11-30 Trustees Of The University Of Pennsylvania Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same

Also Published As

Publication number Publication date
JPH11503028A (ja) 1999-03-23
JP2001029089A (ja) 2001-02-06
DE69635406T3 (de) 2014-04-24
CZ261097A3 (cs) 1998-06-17
CN1827646A (zh) 2006-09-06
AU1689297A (en) 1997-07-14
ES2255716T5 (es) 2014-03-21
JP3288384B2 (ja) 2002-06-04
EP0811063A2 (de) 1997-12-10
CA2213331A1 (en) 1997-06-26
US6797811B1 (en) 2004-09-28
NO327506B1 (no) 2009-07-27
DK1870465T3 (da) 2010-05-17
EP1642975A2 (de) 2006-04-05
MX9706316A (es) 1997-11-29
EP1642975A3 (de) 2006-04-12
EP0811063B9 (de) 2014-04-23
WO1997022698A2 (en) 1997-06-26
US6265184B1 (en) 2001-07-24
HUP9801127A3 (en) 2000-12-28
US20050260565A1 (en) 2005-11-24
JP2001264324A (ja) 2001-09-26
US20080032336A1 (en) 2008-02-07
NO20052202D0 (no) 2005-05-04
CA2213331C (en) 2011-09-27
EP1870465A2 (de) 2007-12-26
EP0811063B2 (de) 2013-12-04
EP0811063B1 (de) 2005-11-09
NO973800L (no) 1997-10-20
CN1183805A (zh) 1998-06-03
DE69635406D1 (de) 2005-12-15
EP1870465A3 (de) 2008-04-23
US20040230037A1 (en) 2004-11-18
ATE309349T1 (de) 2005-11-15
CN1222617C (zh) 2005-10-12
ES2341371T3 (es) 2010-06-18
PL192071B1 (pl) 2006-08-31
PL321937A1 (en) 1998-01-05
US7662548B2 (en) 2010-02-16
NO973800D0 (no) 1997-08-19
NO20052202L (no) 1997-10-20
DK0811063T3 (da) 2006-04-10
AU730463B2 (en) 2001-03-08
EP1870465B1 (de) 2010-02-17
US20020150888A1 (en) 2002-10-17
DE69635406T2 (de) 2006-08-03
HUP9801127A2 (hu) 1998-08-28
DE69638128D1 (de) 2010-04-01
PL192294B1 (pl) 2006-09-29
JP2009065976A (ja) 2009-04-02
WO1997022698A3 (en) 1997-09-12
US6268477B1 (en) 2001-07-31
ES2255716T3 (es) 2006-07-01
SK112897A3 (en) 1998-07-08
BR9607300A (pt) 1997-11-25

Similar Documents

Publication Publication Date Title
ATE458052T1 (de) Verfahren zu chemokinrezeptor 88c
ES2129622T3 (es) Receptores para interleuquina-10 de mamifero.
DE69020143D1 (de) Verfahren zur verwendung und herstellung von peptiden.
NO961115D0 (no) Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser
DE69012636D1 (de) Verfahren zur Trennung von Makromolekülen.
DE69116921D1 (de) Verfahren zur Reinigung von monoklonalen Antikörpern
DE68912114D1 (de) Verfahren zur Trennung von 1,1-Dichlor-1-fluorethan und 1,1,1,3,3-Pentafluorbutan.
DE68913251D1 (de) Verfahren zur Verringerung der Heterogenität von monoklonalen Antikörpern.
ATE291585T1 (de) Traf-inhibitoren
DE59009375D1 (de) Verfahren zur Abtrennung von Riboflavin aus Fermentationssuspensionen.
ATE206621T1 (de) Il-8 antagonisten zur behandlung von asthma
ATE285474T1 (de) Haemophilus adhäsionsproteinen
DE69527707D1 (de) Verfahren unter verwendung von fluidisierten feststoffen und vorrichtung zur durchführung solcher verfahren
FR2528070B1 (fr) Vecteur d'expression porteur d'un codage genetique pour une proteine liant les phosphates, procede pour sa preparation et procede de production d'un polypeptide en l'utilisant
DE19680416D2 (de) Reststoffaufspaltungsverfahren zur Wiedergewinnung von Sekundärrohstoffen
DE3785175D1 (de) A-assoziierte h-antigene, spezifische monoklonale antikoerper und methoden zu deren verwendung zur blutgruppenbestimmung.
DE69229284D1 (de) Unterscheidung von htlv-i und htlv-ii unter verwendung von synthetischen peptiden
DE59004279D1 (de) Verfahren zur C-terminalen Modifizierung von Proteinen.
DE59004174D1 (de) Verfahren zur Abreicherung von Salz aus Biomassesuspensionen.
DE69602928D1 (de) Verfahren zur formgebung keramischer produkte ausgehend von einer wässrigen suspension mit hohem feststoffgehalt
DE59303118D1 (de) Verfahren zur Abtrennung von Acetaldehyd von Kohlenwasserstoffen
DE59007835D1 (de) Verfahren zur Abtrennung von Aromaten.
DE59607930D1 (de) Verfahren zur Einbringung von sich verjüngenden Pfählen, zugehörige Pfähle, und daraus hergestellte Gründungen und Fundamentbildungen
WO2001021794A3 (en) Smad associating polypeptides

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1870465

Country of ref document: EP